Business Context and Reporting Period
This Form 8-K was filed by XpresSpa Group, Inc. (not XWELL, Inc.) on December 12, 2018, reporting events occurring on December 11, 2018. The filing details a material definitive agreement regarding the company's outstanding 5% Secured Convertible Notes due November 16, 2019.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or liquidity figures. The financial impact is limited to the restructuring of debt obligations:
- Debt Instrument: 5% Secured Convertible Notes due November 16, 2019.
- Amortization Waiver: Monthly payments due in January, February, and March 2019 were waived by participating holders.
- Conversion Terms: Participating holders may convert notes into up to 5,000,000 shares of common stock at a conversion price of $0.20 per share.
Material Changes Versus Prior Period
The primary change is the modification of the repayment schedule and conversion rights for a subset of note holders:
- Payment Deferral: Waived monthly payments for the first quarter of 2019 will be spread over the remaining life of the notes.
- Conversion Rights: New conversion privileges were granted to participating holders, allowing conversion into common stock at $0.20 per share.
- Future Price Reduction: Subject to stockholder approval, the company retains the option to further reduce the conversion price at an unspecified future date.
- Partial Participation: Not all note holders entered this agreement; non-participating notes remain governed by the original terms (as amended August 14, 2018).
Guidance, Outlook, and Risks
The filing contains no forward-looking financial guidance or management commentary regarding operational outlook. Key contingencies and risks include:
- Stockholder Approval: The potential future reduction of the conversion price is contingent upon stockholder approval.
- Registration Status: Shares issued upon conversion may not be registered under the Securities Act of 1933 and may be restricted from sale unless an exemption or effective registration statement is available.
- Dilution: The agreement allows for the issuance of up to 5,000,000 shares of common stock, which could dilute existing shareholders.
Investor Verification Checklist
- Verify the exact percentage of total note holders who signed the Second Amendment Agreement versus those who did not.
- Confirm the total principal amount of the notes eligible for conversion under the new terms.
- Review the full text of Exhibit 10.1 (Second Amendment Agreement) for specific covenants and default provisions.
- Monitor upcoming stockholder meetings for votes regarding the potential further reduction of the conversion price.
- Check subsequent filings for any registration statements filed to cover the sale of shares upon conversion.